1. Home
  2. HNI vs ELVN Comparison

HNI vs ELVN Comparison

Compare HNI & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HNI Corporation

HNI

HNI Corporation

HOLD

Current Price

$31.09

Market Cap

2.2B

ML Signal

HOLD

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

HOLD

Current Price

$37.51

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNI
ELVN
Founded
1944
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.6B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
HNI
ELVN
Price
$31.09
$37.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$70.00
$43.40
AVG Volume (30 Days)
700.0K
562.9K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
3.73%
N/A
EPS Growth
N/A
3.17
EPS
N/A
N/A
Revenue
$2,839,000,000.00
N/A
Revenue This Year
$117.19
N/A
Revenue Next Year
$3.68
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.37
N/A
52 Week Low
$28.93
$14.79
52 Week High
$53.29
$48.53

Technical Indicators

Market Signals
Indicator
HNI
ELVN
Relative Strength Index (RSI) 39.17 37.04
Support Level $28.93 $25.63
Resistance Level $47.09 $44.09
Average True Range (ATR) 1.13 2.25
MACD 0.17 -0.49
Stochastic Oscillator 54.34 2.90

Price Performance

Historical Comparison
HNI
ELVN

About HNI HNI Corporation

HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: